Exam I Flashcards
Histo: Where does the cartilage stop?
Bronchioles
-inc. SM, inc. elastic
True/False: Goblet cells, glands and cartilage are not found in the bronchioles, however, SM and elastic fibers are present
True
*SM: diameter
*elastic: expands and contracts
The typical epithelium of the respiratory tract is
- ciliated pseudostratified columnar with goblet cells
- changes at bronchioles: no goblets, no glands, no cartilage
The paranasal sinuses are blind end cavities in the frontal, sphenoid, ehtmoid and maxillary bones. They are lined by respiratory epithelium and drain into the wall of the nasal fossa. These sinuses are considered the
diverticula of the nasal cavity
NOTE: Sinusitis and sinus infections:
- adults: maxillary sinus
- children: ethmoid (halitosis)
The mesothelium + thin layer of CT that covers the lung is known as the _____ pleura. The mesothelium covering the wall of the thoracic cavity is known as the ______ pleura.
Lung: visceral Wall: parietal *serous membranes **90% of mesotheliomas (mesothelial cells - misplace underlying lung alveoli)
The larynx is made up of several cartilages (hyaline and elastic). Extrinsic muscles provide support and movement (deglutition) while intrinsic muscles provide
-phonation and conduit (air flow)
*both are skeletal muscle
The blood-air barrier contains what type of epithelium?
simple squamous
Site where respiration begins
Respiratory bronchioles
Regions of direct air flow have what type of epithelium?
Stratified squamous
Other alveolar cells including endothelial cells, fibroblasts, mast cells, monocytes and macrophages (dust cells) are located in the
interstitium or area between alveolar walls
Neutrophils secrete Elastase which attacks what fibers in the bronchi, bronchioles, alveolar ducts and alveoli?
elastic fibers
Lymphatic nodules in the lamina propria of the bronchioles
BALT
Emphysema is the permanent enlargement of alveoli or air spaces caused by destruction of the alveolar wall. It results from the loss of ____ fibers.
Elastic fibers Results: -thickened vessel walls -accumulate macrophages in alveoli 2 sites: Centriacinar and Panacinar A. Centriacinar: air trapped in respiratory bronchioles B. Panacinar: air trapped in entire resp. unit
Describe the normal epithelial transition in the respiratory portion of the lungs
-ciliated columnar -to ciliated simple cuboidal -to simple squamous
Describe the features of bronchioles
-No cartilage, No glands, -Goblets early -1mm or less in diameter -SM -elastic fibers Terminal portion: Alveoli appear -become respiratory bronchioles
Cystic fibrosis involves production of a defective CFTR (cystic-fibrosis transmembrane conductance regulator), a channel for what ions?
Chloride ions
-CFTR degraded due to defective protein folding
Results:
- decreased Na/C;- reabsorption in sweat glands
- Inc. Na reabsorption (other epithelium) -bronchus, pancreas -Water moves into cells
Differentiate between the conducting portion and the respiratory portion of the lungs
- Conducting -conduction
- hyaline and elastic cartilage
- elastic fibers
- SM (nasal, pharynx, larynx, trachea, bronchi, bronchioles, terminal bronchioles) - Respiratory portion:
- elastic fibers
- SM (respiratory bronchioles, alveolar duct, alveoli)
______ constitute the air passages most often affected in children by measles virus or adenovirus which can cause bronchiolitis (closure of airway due to fibrosis)
Bronchioles
Describe the vascular supply to the pulmonary branches
- Pulmonary artery: deox blood in -travels with conductile and respiratory tree 2. Pulmonary vein: ox blood out -veins: run between septa -Bronchial arteries: taking oxygenated blood to lung tissue (off aorta)
Trachea: True/False: Trachea and Respiratory diverticulum are outgrowths of gut tube
True
Trachea: The trachea is a long tube lined by respiratory epithelium. It has goblet cells, a thick basal lamina and ciliated cells. It is often described as a “ciliary escalator lined by mucous”. The trachea is a part of the ____ portion of the respiratory system
-Conducting portion (inspired and expired air) -16 generations of divisions -continuation from the larynx (inferior limit of cricoid cartilage)
Trachea: List the cells of the trachea
- Ciliated (most common) -sweep mucous -trap dust 2. Basal cells: -base of columnar cells -replace other epithelial cells 3. Goblet (mucous) 4. Brush (receptor cells) -sneeze rflex 5. Small granule (DNES cells) –diffuse neuroendocrine system –hormone secretion (endocrine) –secretory granules (peptide hormones) *cause carcinoid tumors
Nasal cavity: The area/epithelium that is located on the roof of the nasal cavity and medial/lateral nasal wall.
Olfaction area -bipolar neurons (project to olfactory bulb) -CN 1 *pseudostrat. columnar with goblet
Larynx: Below the epiglottis are two pairs of folds: the _____ vocal cords and the ____ vocal cords
- False vocal cord (ventricular folds) 2. True vocal cord (vocal folds) –direct air flow -strat. squamous epithelium -vocalis musscle *reverts back to respiratory epithelium (pseudostratified columnar with cilia and goblet cells) as moves into trachea
Bronchioles: Asthma is a type I HSR. Explain the process by which it induces bronchoconstriction.
-allergen interacts with IgE receptors (mast cells) 1. recruit eosinophils 2. inc. permeability of vessels 3. SM constriction of bronchiioles 4. Hypersecretion of mucus by goblets 5. Mucous plug 6. Charcot-Leyden crystals accumulate from Eosinophils *TH2 cells involved - IL-5 and IL-13
Bronchioles: _____ cells (formerly called clara cells) are found in the smaller bronchioles (terminal and respiratory). They are non-ciliated cells with dome-shaped surface. They display TEM characteristics of protein-secreting cells.
Club cells Secrete: surfactant proteins, mucin, anti-inflammatory protein Function: -proliferation of bronchiolar and alveolar epithelium (replace type II pneumocytes NOTE: Club Cells of the bronchiole = Type 2 Cells of the alveoli
Bronchi: There are 2 primary (mainstem) bronchi that enter the hilum of the lung. ____ bronchi branch off of the primary bronchi, and ____ bronchi branch off of the lobar bronchi
-Lobar bronchi (3R, 2L) branch from primary -Segmental bronchi (2) branch off of Lobar NOTE: -primary bronchi: similar structure to trachea: cartilage rings -Lobar onwards: cartilage plates (dec. cartilage) -Inc. SM as go down *typical epithelium w/goblet and glands *pulmonary artery
Bronchi: Foreign material localizes to different portions of the lung based on if they are in a standing or supine position. 1. In a standing position, the foreign material localizes to ______ 2. in a supine position, it localizes _____ 3. When lying on your right side, foreign material is most likey to go to _____ 4. The most common aspiration site is ______
- Standing: –R. lower lobe (posterobasal segment) 2. Supine: –R. lower lobe (Superior segment) 3. Right sided position: –R. middle lobe (post. segment of R. upper lobe) 4. MC aspiration site –Superior segment of R. lower lobe
Alveoli: Within the wall of the alveolus is the site where O2 and CO2 exchange occurs. This is known as the _______. It involves what cells?
Blood-air barrier 1. Type I pneumocytes 2. Endothelial cels Basal lamina of both cells 3. Pinocytotic vesicles in endothelium
Alveoli: These structures are found in the alveolar septum (wall) that help to equalize pressure and allow for air movement in case other ducts are blocked
Kohn pores
Alveoli: List the features and functions of Type II alveolar (great alveolar) cells
Features: -60% of lining -5% surface area -Secretory by week 28-31 -Lamellar bodies (merocrine) -Foamy cytoplasm Functions: 1. Surfactant secretion – (DPPC - phospholipid) –protein –lipid *lowers alveolar tension 2. Progenitors of type I cells
Alveoli: List the features and functions of Type I alveolar (squamous alveolar) cells
Type I: -40% of entire alveolar lining -high surface area (95%) -junctions (ZO and desmosomes) -morphed Thin: permeability of gases (Blood-air barrier) -pinocytotic vesicles in cytoplasm
Alveoli: Alveoli are thin-walled, sacular structures important for ____. The alveolar wall (interalveolar septum) has several cell types with 2 making up the epithelium facing the air side. Name the cell types composing the alveolar epithelium
Important for: -gas exchange *hollow Cell types: -Type I alveolar cell (Type I pneumocyte; squamous) -Type II alveolar cell (Type II pneumocytes; great)
Alveoli: Alveolar macrophages, also known as Dust cells pass freely between septum and the alveolar lumen. What are they called when they contain rbc’s or hemosiderin (product of rbc breakdown?)
Heart failure cells *Left heart failure of chronic pulmonary edema NOTE: Dust cells are first line of airway defense -remove degraded surfactant -engulf foreign bodies
Diseases of airflow resistance that can involve an obstruction at any level (trachea to respiratory bronchioles).
Obstructive lung disease FEC1/FVC < 0.7 *differentiate from REstrictive via pulmonary function test
Diseases with reduced expansion of lung parenchyma and decreased total lung capacity
Restrictive *cannot breathe in
Obstructive disease: _______ is a disease that involves the alveolar (acinar) spaces. It causes: 1. airspace enlargement (overinflation) distal to the terminal bronchiole 2. destruction of the alveolar wall It is classified according to the anatomic area affected (centriacinar 95% vs. panacinar)
Emphysema Causes: 1. **Cigarette smoke (centriacinar) 2. a1 anti-trypsin deficiency (protease imbalance; panacinar) NOTE: over time, entire alveolar unit (alveoli + capillary vessels) can be destroyed
Emphysema: Several factors contribute to airway obstruction in emphysema. Normally, small airways are held open by the elastic recoil of the lung parenchyma. Loss of elastic tissue in the walls of the alveoli (surrounding the respiratory bronchioles) reduces radial traction and causes the respiratory bronchioles to ______ during expiration.
Collapse of respiratory bronchioles *functional airflow obstruction (despite absence of mechanical obstruction)
Emphysema: Smoking is the MC cause of centrolobular (centriacinar) emphysema. Which of the following is correct about smokers and can contribute to development of emphysema? a. smokers have inc. neutrophils and macrophages in their alveoli b. smoking irritates alveolar macrophages, leading to release of IL-8 (neutrophil chemotactic factor) c. smoking can activate alternative complement pathway d. proteases (e.g. elastase) secreted by neutrophils and macrophages degrade lung tissue
All of the above *nicotine: chemotactic for neutrophils
Emphysema: True/False: Oxidants and free radicals in smoke inhibit alpha-1 anti-trypsin (anti-protease) = dec. protection in alveoli
True
Chronic bronchitis: Chronic bronchitis is a disease associated with excess production of mucous. Smoking interferes with ______ of the respiratory epithelium, and this results in decreased clearance of the mucous.
Interferes with ciliary action (resp. epithelium) -can’t clear mucus -predisposal to secondary and repeated infections
Emphysema: True/False - Paraseptal emphysema can occur adjacent to areas of fibrosis. It commonly occurs in the upper half of the lung and may underlie cases of spontaneous pneumothorax in kids
True *affects distal acini adjacent to pleura
A patient presents with progressive dyspnea, cough and wheezing. He is barrel chested, with prolonged expiration. He sits forward in a hunched position and breathes through pursed lips. Spirometry indicates impaired airflow on expiration. What is his diagnosis?
Emphysema *spirometry = key *classic imaging NOTE: weight loss associated – but can suggest cancer NOTE 2: cough and expectorant are variable (based on extent of associated bronchitis)
The following describes what primary pathophysiology? 1. “pink puffer” 2. FEV1/FVC <0.7 3. destruction of airways distal to terminal bronchiole (including pulmonary capillary beds) 4. decreased ability to oxygenate blood 5. dec. ventilation-perfusion mismatch
Emphysema
Emphysema: How does the body compensate for emphysema (loss of ventilation-perfusion?)
Hyperventilation (“puffer”) –can have normal arterial blood gases (due to compensation) –appear less hypoxemic (“pink” complexion) NOTE: eventual muscle wasting and weight loss (dec. O2)
Hypoxic drive: Normal respiratory drive is based on CO2 in arterial blood (10% based on O2 levels). In emphysema patients, the body is thought to alter the Va/Q ratio to improve gas exchange via _______.
Hypoxic pulmonary vasoconstriction *counteract by O2 therapy *largest inc. of O2-induced hypercapnia
Hypoxic drive: True/False: A titrated oxygen therapy is recommended in patients with an acute exacerbation of COPD to avoid hypoxemia and reduce the risk of oxygen-induced hypercapnia
True Haldane effect also contributes
A 43 year old patient presents with persistent cough and sputum production. She claims she has had the chronic, productive cough for at least 3 months in 2 consecutive years. She states she has smoked 1 pack/day for the past 20 years. What is her most likely diagnosis?
Chronic bronchitis Other symptoms: -dyspnea -hypercapnea, hypoxemia -cyanosis (“blue bloater”; inc. PaCO2, dec. PaO2) -cor pulmonale *absence of any other identifiable cause Histology: -goblet cell hyperplasia -enlarged mucous secreting glands
Chronic Bronchitis: How does the body respond to increased obstruction in a bronchitis patient?
-dec. ventilation, inc. CO -inc. CO2 retention -hypoxemia (V/Q mismatch) -inc. residual lung volume (blue bloater) *blue lips and face
A chronic disorder of the conducting airways that is caused by an immunological reaction. It is marked by episodic bronchoconstriction due to 1. increased airway sensitivity (variety of stimuli) 2. inflammation of bronchial walls 3. increased mucous secretion
Asthma -episodic, hyperactive (hyper-responsive), reversible airway disease
Asthma: A 6 year old girl presents to the clinic accompanied by her mother who complains her daughter has had episodic wheezing with cough and shortness of breath. You note hyperexpansion of the chest, rapid pulse and increased mucous production. You suspect
Asthma –MC chronic respiratory disease in children –Type I HSR -bronchoconstriction (bronchial walls) *bronchi and terminal bronchioles
Atopic (extrinsic) asthma is due to exaggerated TH2 lymphocytes and _____ response to environmental allergens (in genetically predisposed).
IgE –response to harmless Ag -other allergic disorders -may present before 5y/o
Asthma: Early phase involves the stimulation of ______ and release of what interleukins?
Stimulation of TH2 -IL-4 (IgE) -IL-5 (eosinophils) -IL-10 (TH2)
Asthma: Late phase reaction occurs 4-8 hours later and involves what cells?
Eosinophils -MBP (damages epithelial cells) -Eotaxin = chemotactic for eosinophils -bronchoconstriction
Nont-atopic asthma occurs in patients without other atopic (allergic) disease. It typically manifests later in life (adulthood) or can be associated with cold, exercise or infections (viral). What are typical findings of non-atopic asthma?
-no assicated allergies -normal IgE -no family Hx -includes drug-induced type ex: viral infection, exercise, cold air, cigarette smoke, ozone, aspirin (nasal polyps; bronchoconstriction)
Nasal polyps in children under the age of 2 may be associated with what disease?
Cystic fibrosis
A type of obstructing disease that is caused by chronic necrotizing infections that destroy SM and elastic tissue leading to permanent dilation of the bronchi and bronchioles. “A patient presents with purulent, foul smelling sputum, and hemoptysis. He has a history of recurrent infections.”
Bronchiectasis *purulent sputum (foul smell) *recurrent infections *hemoptysis
Bronchiectasis: The following are common causes of bronchiectasis: 1. Kartagener (sinusitis; dynein arm of cilia) 2. tumor 3. cystic fibrosis 4. allergic bronchopulmonary aspergillosis Of these, what is the most common cause of bronchiectasis?
Cystic Fibrosis (AR) *affects lower lobes *pus NOTE: Young patient w/ recurrent infections and malabsorption (cystic fibrosis)
An inherited disorder of ion transport that affects fluid secretion in exocrine glands in the epithelial lining of the respiratory, GI and reproductive tracts. *multi-system disease
Cystic fibrosis *abnormally viscous secretions (mucoviscidosis)
Cystic fibrosis is an AR disorder that results from abnormal function of an epithelial chloride channel protein encoded by the CFTR gene on chromosome: 7q31.2. The functions of CFTR are tissue specific, as are the effects. What are the effects in the lungs?
-dehydration = defective mucociliary action -accumulation of hyperconcentrated, viscid secretions -obstruct air passages -predispose to recurrent pulmonary infections
With cystic fibrosis, symptoms may appear at any point in life with a wide degree of phenotypic variation. Why is this so?
-diverse mutations in the gene associated with cystic fibrosis -tissue-specific effects of the encoded gene product -influence of so-called modifier genes
Cystic fibrosis decreases chloride secretion and increases sodium and water reabsorption. This leads to dehydration of the mucous layer coating the epithelium. As a result, mucociliary action becomes defective and mucus plugs the airways. What is a way to test for cystic fibrosis?
Production of hypertonic sweat
*positive sweat chloride test
*altered membrane potential test
*tryptophan
NOTE: CF - Phe508 mutation (7q31.2); ATP binding, protein misfolding (CFTR)
Cystic fibrosis can cause significant pathologic changes affecting numerous systems in the body. Some of these include: 1. unaffected sweat glands 2. azoospermia and infertility 3. congenital bilateral absence of vas deferens Pulmonary changes pose the most serious complications of this disease. Describe respiratory changes associated with cystic fibrosis?
- secondary changes to viscous mucous secretions –(submucosal glands) 2. obstruction and infection of air passages 3. bronchioles distended w/ thick mucous –marked hyperplasia and hypertophy of mucous secreting cells 4. sumperimposed infections –severe chronic bronchitis/bronchiectasis 5. lung abscesses
True/False: In addition to genetic factors (class of mutation), different environmental factors can influence the severity and progression of lung disease in cystic fibrosis patients. These factors can include: 1. virulent organisms 2. efficacy o ftherapy 3. intercurrent and concurrent infections by other organisms 4. tobacco or other allergens
True
What are the three most common organisms for lung infections in cystic fibrosis patients?
- Staph aureus –gram + cocci in clusters –necrotizing or cavitary (MRSA) 2. Haemoph. influenza 3. Pseudomonas aeruginosa *** NOTE: mucoid form of P. aeruginosa is frequent (chronic inflammation; alginate production)
Severe illness can occur in CF patients with what type of pseudomonas infection?
Burkholderia cepacia complex *severe illness
What fungi is commonly associated with lung infections in CF patients?
allergic bronchopulmonary aspergillosis
Most common cause of death in patients involves cardiorespiratory complications (persistent lung infections, COPD, cor pulmonale). What are causes of recurrent infections?
–indiscriminate use of antibiotic prophylaxis against Staph – led to resistant pseudomonas *most patients with CF harbor P. aeruginosa or B capacia
True/False: Individuals who carry one “severe” and one “mild” CFTR mutation may develop late-onset mild pulmonary disease, another example of nonclassic or atypical cystic fibrosis
True
Diagnosis of cystic fibrosis is based upon compatible clinical findings with biochemcial or genetic confirmation. The sweat chloride test is the mainstay of laboratory confirmation. What are the criteria that must be met to confirm CF?
Both criteria must be met: 1. Clinical symptoms consistent with CF in at least one organ system, AND 2. Evidence of cystic fibrosis transmembrane conductance regulator (CFTR) dysfunction (any of the following): a. Elevated sweat chloride ≥60 mmol/L (on two occasions) b. Presence of two disease-causing mutations in CFTR, one from each parental allele c. Abnormal nasal potential difference
True/False: Genetic analysis by sequencing the CFTR gene can capture about 90% of the mutations present in general population (higher sensitivity for Ashkenazi Jew population, lowest for Hispanic). Genetic testing also used in pre-conception screening for families with a known history.
True
A patient presents with his wife who complains her husband has repeated and chronic cessation of breathing during sleep that lasts >10 seconds. She states he breathes noisily and snores loudly at night. He admits to daytime sleepiness (hypersomnolence) and fatigue. He is at risk of endocrine abnormalities (hormones released at night). You suspect
Sleep apnea
*Dx: polysomnography (sleep study)
NOTE: chronic changes 2o to chronic nocturnal hypoxia: -pulmonary HTN
- systemic HTN (elevated Hb and RBC (polycthemia)
- 2o to erythropoietin released in response to low O2
Obstructive sleep apnea is associated with elevated body mass index > 30 (obesity). This is due to: a. obesity contributes to hypoventilation (poor air movement) b. respiratory effort obstructed c. diminished diaphgragmatic excursion e. upper airway laxity/excess tissue
All of the above e. Excess tissue –post. pharynx mucosal tissue –tonsillar hypertrophy (kids) NOTE: associated with polycthemia, RHF (cor pulmonale) Tx: weight loss, CPAP, surgery, reduce tonsil size, uvula, etc.
Type of sleep apnea caused by injury to the CNS (trauma, surgery, meds - opiates, barbs). It can be seen in heart failure. Common features include:
- Cheyne stokes respirations –progressively deeper/faster breathing followed by dec. apneic episodes
–every 30-120 seconds
Central sleep apnea
Tx: address underlying condition, CPAP
Obstructive Drugs: Describe the actions of the following on Bronchial Tone: 1. Acetylcholine 2. Epinephrine 3. Histamine & Leukotrienes 4. Prostaglandins
- Acetylcholine –Muscarinic Receptors (parasympathetic) –CONSTRICTION 2. Epinephrine B2 receptors (sympathetic) –DILATION 3. Histamine & Leukotrienes H-1 & LTD4 and LTE4 Receptors –CONSTRICTION 4. Prostaglandins –PGE2 causes DILATION –PGF2α causes constriction
Obstructive drugs - Bronchodilators: B2 receptor agonists are sympathomimetic, and thus cause bronchodilation of SM. These include:
- Epinephrine
- Short acting Beta-2 selective agonists (SABA)
- Long acting B2 agonist (LABA)
What is their mechanism of action?
Increased cAMP = relax SM
Obstructive drugs - Bronchodilators: B2 receptor agonists are sympathomimetic, and thus cause bronchodilation of SM. These include: 1. Epinephrine 2. Short acting Beta-2 selective agonists (SABA) 3. Long acting B2 agonist (LABA) ________ is non-selective (alpha and beta receptors). It is used in EMERGENCIES and will cause CV stimulation.
Epinephrine (epi-pen) *B1 - heart -a1 b.v.’s *increase heart rate and b.p.
Obstructive drugs - Bronchodilators: B2 receptor agonists are sympathomimetic, and thus cause bronchodilation of SM. These include: 1. Epinephrine 2. Short acting Beta-2 selective agonists (SABA) 3. Long acting B2 agonist (LABA) _____ include albuterol and Levalbuteral. These act as “rescue” inhalers.
SABA’s –oral inhalation for ACUTE bronchospasm *albuterol = okay for pregnancy
Obstructive drugs - Bronchodilators: B2 receptor agonists are sympathomimetic, and thus cause bronchodilation of SM. These include: 1. Epinephrine 2. Short acting Beta-2 selective agonists (SABA) 3. Long acting B2 agonist (LABA) _____ include salmeterol (used for pregnancy). They are useful for: 1. nocturnal asthma 2. exercise induced bronchospasm 3. inhibit late phase allergen-induced bronchoconstriction (after SABA’s wear off)
LABA’s *salmuterol NOTE: not for monotherapy (inc. mortality) *not rescue inhalers
Obstruction drugs - Bronchodilators: _______ is a bronchodilator of the methylxanthine class (caffeine). It is a PDE inhibitor (inc. cAMP = SM relax).
Theophylline –inhibits mucous, histamine Adverse: -cardiac stimulation (“wired” palpitations/tachy) -NO TRUE antidote for overdose NOTE: similar to milrinone (HF)
Obstruction drugs - Bronchodilators: _____ are muscarinic receptor antagonists (LAMAs). They are best used for patients with COPD and severe asthma.
Ipratropium and tiotropium (LAMAs) *synergistic w/ B2 agonists Adverse: –dry mouth (inhalation) –urine retention (BPH,)
Obstruction drugs - Anti-inflammatories: Coticosteroids (glucocorticoids) are anti-inflammatory drugs that act by -decrease inflammation -dec. edema -dec. histamine They come in both systemic and inhaled forms. They can be used as a prophylactic. What is important to consider with regard to using corticosteroids for Tx?
Still have to use rescue inhaler NOTE 2: DO NOT STOP chronic Tx abruptly (must be tapered - up to 5 days)
Obstruction drugs - Anti-inflammatories: Coticosteroids (glucocorticoids) are anti-inflammatory drugs that act by
- decrease inflammation
- dec. edema
- dec. histamine
What are examples of orally inhaled corticosteroids (ICS)? When are they used?
- beclemthasone
- fluticasone
- budesonide (pregnancy)
*lipid soluble (control symptoms)
*adjunct to bronchodilators *slow onset - weeks
Obstruction drugs - Anti-inflammatories: Coticosteroids (glucocorticoids) are anti-inflammatory drugs that act by -decrease inflammation -dec. edema -dec. histamine What are examples of nasally inhaled corticosteroids (ICS)?
- Beclomethosone 2. Triamcinolone *similar to orally inhaled
Obstruction drugs - Anti-inflammatories: Coticosteroids (glucocorticoids) are anti-inflammatory drugs that act by -decrease inflammation -dec. edema -dec. histamine What are adverse effects of ALL inhaled steroids?
- fungal growth (candida albicans) others: hoarseness; suppress HPA-axis, growth retardation NOTE: use smallest effective dose in kids; drink water
Obstruction drugs - Anti-inflammatories: Mast cell stabilizers bind to and stabilize mast cells. They also prevent Ca2+ influx. They can be taken as oral or nasal inhalants, but take 2-4 weeks for effects. What is an example of a mast cell stabilizer? When is it appropriate to use?
Cromolyn –modest effects –safe for adults: lung irritation, mood changes –no direct anti-inflammatory effect NOTE: PROPHYLACTIC only!! (not for acute Tx) NOTE 2: Prevent exercise induced bronchospasm (1/hr pre-exercise)
Obstruction drugs - Anti-inflammatories: Leukotriene antagonists include _____ and ____. They act to prevent inflammation, edema, bronchoconstriction and formation of thick/viscous mucous.
Zafirlukast and Montelukast (singulair) *inhibit early and late phases of constriction *prevent inflammation, edema, bronchoconstrict…
Obstruction drugs - Anti-inflammatories: Leukotrienes are a primary mediator of asthma in humans. Leukotriene antagonists, such as Zafirlukast and Montelukast can be used as alternative Tx for 1. long term management of mild-moderate asthma 2. OR for prevention of exercise induced bronchospasm. What are contraindications of these drugs?
NOT for: -acute asthma -constriction -acute exercise induced bronchospasm -monotherapy (need SABA) NOTE: montelukast = less adverse effects
What does every person with asthma need?
SABA
Obstruction drugs - Anti-inflammatories: Zileuton is a _______. It inhibits 5-lipoxygenase (converts arachidonic acid to leukotrienes).
Leukotriene synthesis inhibitor *mild to moderate asthma **Expensive!! Poor compliance Adverse: headaches, respiratory infections
Obstruction drugs: Anti-IgE therapy may be used in asthma patients ONLY when ________. Adverse effects: -headache, injection site reactions
Only when known IgE-mediated allergies present ex: OmalEzumab NOTE: may cause major hypersensitivity reaction/anaphylaxis (severe)
Obstruction drugs: List the drugs that are contraindicated in asthma patients
- all Cholinergic Drugs
* –M agonists (bronchoconstrict) - Systemic anti-M drugs
* –adverse effects - Beta blockers (non-selective)
* –bronchoconstrict - Histamine releasing drugs
* –constrict (tubocurarine, morphine) - NSAIDS
- –aspirin
- ** –block PGE2, promote PGF2